ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

STIM Neuronetics Inc

2,02
-0,04 (-1,94%)
14 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Neuronetics Inc STIM NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,04 -1,94% 2,02 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
2,06 1,94 2,0771 2,02 2,06
mais cotações »

Notícias Recentes

Data Hora Fonte Título
13/06/202409:31GLOBENeuroStar Showcases Cutting-Edge Research at Clinical TMS..
23/05/202409:30GLOBENeuronetics to Present at the William Blair 44th Annual..
15/05/202408:32GLOBEHumana Is First Commercial Payer to Address TMS Therapy..
07/05/202408:30GLOBENeuronetics Reports Record First Quarter 2024 Financial and..
03/05/202417:30GLOBENeuronetics Reports Inducement Grant Under Nasdaq Listing..
01/05/202409:31GLOBENeuroStar® TMS Advances Treatment for Adolescents During..
23/04/202417:30GLOBENeuronetics to Report First Quarter 2024 Financial and..
10/04/202409:31GLOBENew Publication in Brain Stimulation Confirms Full TMS..
27/03/202417:30GLOBENeuronetics Reports Inducement Grant Under Nasdaq Listing..
25/03/202409:30GLOBENeuroStar® Advanced Therapy Receives FDA Clearance as a..
07/03/202410:22GLOBENeuronetics Announces 5-Year Exclusive Partnership with..
05/03/202409:30GLOBENeuronetics Reports Record Fourth Quarter and Record Full..
20/02/202410:30GLOBENeuronetics to Report Fourth Quarter 2023 Financial and..
12/02/202410:32GLOBENeuronetics Launches Latest Evolution in its TrakStar®..
06/02/202410:28GLOBENeuroStar TMS Patient Access Expands Through Lucet Health..
08/01/202410:30GLOBENeuronetics Reports Preliminary Fourth Quarter and Fiscal..
18/12/202310:49GLOBENeuronetics Receives 510(k) Clearance for NeuroSite™ Coil..
04/12/202310:56GLOBENeuroStar TMS Receives Expanded Regulatory Approval in Japan
15/11/202318:15GLOBENeuronetics to Present at the 35th Annual Piper Sandler..
13/11/202310:57GLOBENeuroStar Elevates Depression Treatment with Cutting-Edge..
09/11/202310:32GLOBENeuronetics Announces Continued Momentum from Health Plans..
07/11/202309:30GLOBENeuronetics Reports Third Quarter 2023 Financial and..
06/11/202318:30GLOBENeuronetics Reports Inducement Grant Under Nasdaq Listing..
24/10/202309:30GLOBENeuronetics to Report Third Quarter 2023 Financial and..
16/10/202309:56GLOBEBrain Stimulation Highlights Best Practices for Optimal TMS..
03/10/202310:21GLOBENeuronetics Draws Down Remaining $22.5 Million Available..
12/09/202309:56GLOBEIn Recognition of Suicide Prevention Month, NeuroStar Voices..
21/08/202309:56GLOBENeuroStar Advanced Therapy Wins 2023 dotCOMM Awards
14/08/202310:02GLOBENeuronetics Revolutionizes Patient Communication and..
08/08/202308:30GLOBENeuronetics Reports Record Second Quarter 2023 Financial and..
04/08/202317:30GLOBENeuronetics Reports Inducement Grant Under Nasdaq Listing..
25/07/202309:30GLOBENeuronetics to Report Second Quarter 2023 Financial and..
19/07/202309:56GLOBENeuronetics Announces Expanded TMS Therapy Access Through..
17/07/202309:46GLOBENeuroStar Achieves Milestone Regulatory Clearance in South..
11/07/202309:56GLOBENeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For..